Maximus, Inc. (NYSE:MMS) Stake Raised by Deerfield Management Company L.P. Series C

Deerfield Management Company L.P. Series C lifted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 453.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,563 shares of the health services provider's stock after buying an additional 11,111 shares during the period. Deerfield Management Company L.P. Series C's holdings in Maximus were worth $1,162,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in MMS. Rise Advisors LLC grew its stake in shares of Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider's stock worth $26,000 after purchasing an additional 289 shares in the last quarter. GAMMA Investing LLC increased its stake in Maximus by 224.5% during the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock valued at $29,000 after buying an additional 238 shares during the period. Blue Trust Inc. increased its stake in Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock valued at $33,000 after buying an additional 262 shares during the period. Kapitalo Investimentos Ltda bought a new stake in shares of Maximus during the 4th quarter worth about $52,000. Finally, Archer Investment Corp lifted its stake in shares of Maximus by 8,788.9% in the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock worth $69,000 after acquiring an additional 791 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Price Performance

Shares of Maximus stock traded down $0.90 on Thursday, hitting $91.79. The company had a trading volume of 526,364 shares, compared to its average volume of 355,997. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $93.97. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59. The company has a market cap of $5.58 billion, a PE ratio of 24.09 and a beta of 0.76. The business has a 50-day simple moving average of $89.87 and a 200-day simple moving average of $86.31.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.27. The company had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period last year, the firm earned $0.78 EPS. Research analysts expect that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date was Thursday, August 15th. Maximus's payout ratio is 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.